Comparative efficacy and safety of neoadjuvant radiotherapy for patients with borderline resectable, and locally advanced pancreatic ductal adenocarcinoma: a systematic review and network meta-analysis protocol
Introduction The optimal dose and treatment modality of neoadjuvant radiotherapy applied for treating borderline resectable and locally advanced pancreatic ductal adenocarcinoma (PDAC) have been debated topics in oncology. The objective of the present network meta-analysis (NMA) is to study and comp...
Saved in:
| Main Authors: | Xin Wang, Dan Cao, Qingfeng Wang, Qiancheng Hu, Wanrui Lv |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2022-07-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/12/7/e050558.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Long‐Term Outcomes of Neoadjuvant Therapy Versus Upfront Surgery for Resectable Pancreatic Ductal Adenocarcinoma
by: Kyung In Shin, et al.
Published: (2024-11-01) -
Obstructive sleep apnea predicts pathologic response to neoadjuvant therapy in resected pancreatic ductal adenocarcinoma
by: Sami Shoucair, et al.
Published: (2022-12-01) -
Neoadjuvant Stereotactic Ablative Radiotherapy in Pancreatic Ductal Adenocarcinoma: A Review of Perioperative and Long-Term Outcomes
by: Robert Michael O’Connell, et al.
Published: (2025-07-01) -
Prediction of early recurrence of pancreatic ductal adenocarcinoma after resection.
by: Toshitaka Sugawara, et al.
Published: (2021-01-01) -
Kidney Transplantation after Extended Multivisceral Resection for Pancreatic Ductal Adenocarcinoma
by: Hryhoriy Lapshyn, et al.
Published: (2018-01-01)